×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Head & Neck Cancer

Jessica Skarzynski
Because little is known about the effect of patients' sex on the efficacy of immune checkpoint inhibitors as cancer treatments, the researchers performed a systematic review and meta-analysis to determine the heterogeneity of immune checkpoint inhibitor efficacy between men and women.
Kristie L. Kahl
In a presentation at the 2018 ASCO Annual Meeting, researchers from Kaiser Permanente also found that women were almost twice as likely to die from the disease compared with non-cancer deaths.
Nosayaba Osazuwa-Peters, BDS, MPH, CHES
As cancer survivors are living longer thanks to new treatments, it is essential that health care providers and researchers put more focus on depression.
Beth Fand Incollingo
John Mahoney, famous for playing Mar- tin Crane, father of the title character on the TV show “Frasier,” died of throat cancer on Feb. 4 while in hospice care, according to the Chicago Tribune.
Brenda Denzler
Cancer survivors worry about recurrence, but seldom think about their risk for new primaries.
Brielle Urciuoli
Patients with head and neck cancer experienced a decrease in symptom severity after using mobile and sensor technology that allowed their health care providers to remotely monitor symptoms, according to research that will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Brielle Urciuoli
When compared to chemotherapy, the immunotherapy agent had better outcomes both in quality of life and survival.
Brielle Urciuoli
Higher carbohydrate and sugar intake was correlated with worse outcomes in patients with head and neck cancer, according to the study.
Brielle Urciuoli
The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.
Brielle Urciuoli
After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other